Product Information
TEMOZOLOMIDE 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $4.3755 per EA under NDC 16571081841. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Apr 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571081841
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206309FDA Approved
4/27/2016
TE Code
AB
On Market Since
10/4/2022
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 100 MG CAPSULE has been published 124 times since May 22, 2024, and over the history we have for it it has declined 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3755 per EA |
|---|---|
| All-time high | $13.5895 (Feb 12, 2025) |
| All-time low | $4.3755 (Sep 23, 2026) |
| 52-week high | $10.3266 |
| 52-week low | $4.3755 |
| Median price | $9.0779 |
| Average price | $9.5673 |
| Largest weekly change | +34.3% (Oct 23, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
temozolomide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Alkylating Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $4.3755 per EA (NDC 16571081841), effective Sep 30, 2026.
How has the price of TEMOZOLOMIDE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has declined 51.1%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 100 MG CAPSULE?
Since May 22, 2024, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has ranged from a low of $4.3755 (Sep 23, 2026) to a high of $13.5895 (Feb 12, 2025), with a median of $9.0779 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 100 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TEMOZOLOMIDE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 100 MG CAPSULE?
TEMOZOLOMIDE 100 MG CAPSULE (NDC 16571081841) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.